Pomalidomide, Dexamethasone, And Daratumumab After Lenalidomide Treatment In Relapsed Refractory Multiple Myeloma: Updated Results From An Open-Label, Multicenter, Phase 2 TrialDavid S. Siegel,Gary J. Schiller,Christy J. Samaras,Michael Sebag,Jesus G. Berdeja,Siddhartha Ganguly,Jeffrey V. Matous,Kevin W Song,Christopher S. Seet,Mirelis Acosta-Rivera,Michael Bar,Donald P. Quick,Bertrand M. Anz,Gustavo A. Fonseca,Donna E. Reece,Kim Lee,Weiyuan Chung,Amit Agarwal,Nizar J. BahlisBLOOD（2020）引用 6|浏览36暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
